Cobalt

• Relieves low back pain * Uses: See symptoms on front panel.

Adults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.

1. 1Drug Hypersensitivity1743%
2. 2Dyspnoea410%
3. 3Hypersensitivity410%
4. 4Off Label Use410%
5. 5Abdominal Pain37.5%
6. 6Alopecia37.5%
7. 7Arthralgia37.5%
8. 8Covid-1937.5%
9. 9Heart Rate Increased37.5%
10. 10Intentional Product Use Issue37.5%
11. 11Migraine37.5%
12. 12Mitral Valve Prolapse37.5%
13. 13Pneumonia37.5%
14. 14Rash37.5%
15. 15Chest Discomfort25.0%

Recent PubMed references pinned to Cobalt as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

• The hybrid drug delivery system of TCPP-Co, β-cyclodextrin and piroxicam: Spectroscopic characterization, morphological reorganization and controlled release dynamics.
  Pakistan journal of pharmaceutical sciences · 2026 · Khaliq S, Najaf Iqbal D, Mazher M, et al.
  PMID 42262210DOI 10.36721/PJPS.2026.39.8.236.1
• Catalase-like activity of Co(2+)-MOF/CNTs nanocomposite for in situ electrochemical sensing of H(2)O(2) in living cells.
  Mikrochimica acta · 2026 · Zhou Y, Zhu L, Li M, et al.
  PMID 42250020DOI 10.1007/s00604-026-08189-y
• Real-time in-situ H(2)O(2) quantification in high-biomass marine environments with a robust NiCo-MOF nanosheet electrode.
  Analytica chimica acta · 2026 · Zhao D, Lu Y, Mao H, et al.
  PMID 42219639DOI 10.1016/j.aca.2026.345658
• Targeting Cancer Cells With Co(III)-Bipyridyl Complex: A Combined In Vitro and In Silico Study on U87MG and ME-180 Cell Lines.
  Chemistry & biodiversity · 2026 · Sultana S, Maity T, Kundu P, et al.
  PMID 42216859DOI 10.1002/cbdv.71370
• Hemoglobin-assisted, ZIF-derived porous bimetallic FeCo/N-C nanozyme with high oxidase-like activity for colorimetric sensing.
  Mikrochimica acta · 2026 · Wang Z, Chen Y, Lin X, et al.
  PMID 42209727DOI 10.1007/s00604-026-08155-8
• Antitumor efficacy of cobalt-zinc ferrite nanoparticles on MCF-7 cell line and Ehrlich ascites carcinoma bearing mice.
  Scientific reports · 2026 · Elwan MM, El-Nahass EE, El-Naggar SA, et al.
  PMID 42209718DOI 10.1038/s41598-026-54344-z
• An Evaluation of Cage Amine Sarcophagine Ligands for the Synthesis of Cobalt Radiopharmaceuticals.
  Inorganic chemistry · 2026 · Houson HA, Rudd SE, Fernandez SR, et al.
  PMID 42201774DOI 10.1021/acs.inorgchem.6c01482
• Magnetic recyclable CoFe(2)O(4)/lignin spheres: Enhanced peroxydisulfate activation for neonicotinoid insecticide remediation.
  Environmental research · 2026 · Shi Q, Li J, Wang Y, et al.
  PMID 42176945DOI 10.1016/j.envres.2026.124808

The 10 most recently updated of 256 ClinicalTrials.gov registrations naming Cobalt as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

• Study Assessing Two Models of Hypofractionated Protontherapy on Large Choroidal Melanomas
  Terminated · Interventional · 32 enrolled · Centre Antoine Lacassagne
  NCT02602756updated 2026-06-12
• Proton Beam Therapy for Chordoma Patients
  Active not recruiting · Phase 2 · Interventional · 19 enrolled · M.D. Anderson Cancer Center
  NCT00496119updated 2026-06-12
• 131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)
  Recruiting · Phase 1 · Interventional · 24 enrolled · Columbia University
  NCT07015684updated 2026-06-10
• Siplizumab for Sickle Cell Disease Transplant
  Terminated · Phase 1 · Phase 2 · Interventional · 1 enrolled · Columbia University
  NCT06078696updated 2026-06-10
• Polymer-free Sirolimus Eluting Stent: Real-world Investigation of Safety and Outcomes
  Not yet recruiting · Observational · 300 enrolled · Dorian Garin
  NCT07563231updated 2026-06-09
• Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
  Recruiting · Interventional · 150 enrolled · Teleflex
  NCT06779630updated 2026-06-03
• Comparison of Laboratory-Fabricated and 3D-Printed Rapid Maxillary Expansion Appliances
  Active not recruiting · Interventional · 48 enrolled · Baskent University
  NCT07599202updated 2026-05-20
• Optimal Treatment for Coronary Drug Eluting Stent In-stent Restenosis
  Completed · Interventional · 108 enrolled · Semmelweis University Heart and Vascular Center
  NCT04862052updated 2026-05-19
• Ischemic and Bleeding Outcomes After Angiolite Stent Implantation and an Abbreviated Dual Antiplatelet Therapy
  Active not recruiting · Phase 3 · Interventional · 2,312 enrolled · iVascular S.L.U.
  NCT05952206updated 2026-05-15
• A Tailored and Digital Approach to Address Equity and Support Well-being for Healthcare Workers in the Era of COVID
  Completed · Interventional · 293 enrolled · University of Pennsylvania
  NCT05931432updated 2026-05-08

Frequently asked questions

What is Cobalt used for?

According to FDA labeling, Cobalt carries indications including: Relieves low back pain * Uses: See symptoms on front panel.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.

What class of drug is Cobalt?

Cobalt is classified as Standardized Chemical Allergen, Cell-mediated Immunity, Increased Histamine Release.